Cross-priming of T cells to intracranial tumor antigens elicits an immune response that fails in the effector phase but can be augmented with local immunotherapy

Simona Velicu, Yu Han, Ilya Ulasov, Ian Elliott Brown, Abdel El Andaloussi, Thomas F. Gajewski, Maciej S. Lesniak

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'Cross-priming of T cells to intracranial tumor antigens elicits an immune response that fails in the effector phase but can be augmented with local immunotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences